期刊文献+

实时荧光定量PCR检测结直肠癌hPTTG1的表达及其意义 被引量:4

Expression of Human Pituitary Tumor Transforming Gene 1 in Colorectal Cancer Detected with Real-time Fluorescent Quantitative PCR and Its Clinical Significance
下载PDF
导出
摘要 背景与目的:虽然人垂体瘤转化基因1(human pituitary-tumor transforming gene1,hPTTG1)在结直肠癌等恶性肿瘤中高表达,然而hPTTG1 mRNA与结直肠癌临床病理参数之间的关系及其能否作为结直肠癌诊断和预后判断的分子标志尚不清楚。本研究检测hPTTG1 mRNA在结直肠癌中的表达,分析其与临床病理参数之间的关系,探讨hPTTG1 mRNA作为结直肠癌诊断和转移复发的分子标志的可能性。方法:采用实时荧光定量PCR检测结直肠癌组织与对应癌旁组织hPTTG1 mRNA,并分析其与临床病理指标的关系。结果:结直肠癌组织hPTTG1mRNA表达较正常癌旁组织显著增高(0.42±0.07vs.0.03±0.01,P<0.001)。hPTTG1 mRNA与肿瘤大小、血清CEA水平有关,肿瘤直径≥3.5cm较<3.5cm显著增高(15.80±8.80vs.10.91±5.22,P<0.05),血清CEA>5ng/mL较<5ng/mL显著增高(22.79±7.42vs.9.39±2.61,P<0.001)。hPTTG1mRNA在Dukes'C、D期显著高于Dukes'A、B期(15.88±8.09、25.69±7.67vs.9.03±0.35、9.58±2.93,P<0.001)。伴有淋巴转移、肝转移或其他器官转移者(17.63±8.47、31.07±4.10和22.78±6.39)较无转移者(11.15±6.65)显著增高(P<0.001)。hPTTG1 mRNA与患者的性别、年龄和病理分型无关(P>0.05)。结论:hPTTG1 mRNA在结直肠癌中高表达,与结直肠癌的疾病进展密切相关,有助于对患者病情进展的预测。 BACKGROUND & OBJECTIVE: Although human pituitary tumor transforming gene 1 (hPTTG1) is overexpressed in malignant tumors such as colorectal cancer, its correlation to clinicopathologic parameters and its value in diagnosis and prognosis prediction of colorectal cancer are still not clear. We investigated the expression of hPTTG1 in colorectal cancer tissues, and elucidated its correlation to some clinicopathologic parameters of colorectal cancer. METHODS:The expression of hPTTG1 in 60 specimens of colorectal cancer and corresponding noncancerous tissues were examined with real-time fluorescent quantitative polymerase chain reaction, and its correlation to seven clinicopathologic parameters were analyzed. RESULTS: The mRNA level of hPTI-G1 was significantly higher in colorectal cancer tissues than in corresponding noncancerous tissues (0.42±0.07 vs. 0.03±0.01, P〈0.001), significantly higher in colorectal cancer tissues with serum CEA level of 〉 5 ng/mL than in those with CEA of 〈 5 ng/mL (22.79±7.42 vs. 9.34±2.61, P〈0.001), significantly higher in colorectal cancer tissues with diameter of ≥ 3.5 cm than in those with diameter of 〈 3.5 cm (15.80±8.80 vs. 10.91±5.22, P〈0.05), significantly lower in Dukes'A, B tumors than in Dukes' C, D tumors (9.03±0.35 and 9.58±2.93 vs. 15.88±8.09 and 25.69± 7.67, P〈0.001), and significantly higher in colorectal cancer tissues with lymph node metastasis (17.63 ±8.47), liver metastasis (31.07±4.10) and other organ metastasis (22.78 ±6.39) than in those without metastasis (11.15±6.65) (P〈0.001). hPTTG1 expression had no relationship with patients' age, sex and histological type (P〉0.05). CONCLUSIONS: hPTTG1 is overexpressed in colorectal cancer. It is closely related to the progression of colorectal cancer, and may be helpful for prognosis prediction of colorectal cancer.
出处 《癌症》 SCIE CAS CSCD 北大核心 2008年第11期1217-1221,共5页 Chinese Journal of Cancer
关键词 结直肠肿瘤 人垂体瘤转化基因1 实时荧光定量 PCR Colorectal neoplasm Human pituitary-tumor transforming gene1 Real-time fluorescent quantitative PCR
  • 相关文献

参考文献10

  • 1Ramaswamy S, Ross K N, Lander E S, et al. A molecular signature of metastasis in primary solid tumors [J]. Nat Genet, 2003,33 ( 1 ) : 49-54.
  • 2Zou H, McGarry T J, Bernal T, et al. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis [J]. Science, 1999,285 (5426) :418-422.
  • 3Hamid T, Kakar S S. PTTG/securin activates expression of p53 and modulates its function [J]. Mol Cancer, 2004,3:18.
  • 4Heaney A P, Singson R, McCabe C J, et al. Expression of pituitary-tumour transforming gene in colorectal tumours [J]. Lancet, 2000,355 (9205) : 716-719.
  • 5Klein D. Quantification using real-time PCR technology: applications and limitations [J]. Trends Mol Med, 2002,8 (6) : 257-260.
  • 6张青云,孙丽,张书耕,王琼.时间分辨荧光免疫法与电化学发光法检测结直肠肿瘤标志CEA的比较[J].世界华人消化杂志,2005,13(23):2799-2802. 被引量:8
  • 7Kanellos I, Zacharakis E, Kanellos D, et al. Prognostic significance of CEA levels and detection of CEA mRNA in draining venous blood in patients with colorectal cancer [J]. J Surg Oncol, 2006,94( 1 ) : 3-8.
  • 8Liska V, Holubec L Jr, Treska V, et al. Dynamics of serum levels of tumour markers and prognosis of recurrence and survival after liver surgery for colorectal liver metastases [J ]. Anticancer Res, 2007,27 (4C) : 2861-2864.
  • 9Uehara M, Manaka D, Baba S, et al. prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer [J]. Gan To Kagaku Ryoho, 2007,34(9) : 1413-1417.
  • 10Irvine T, Scott M, Clark C I. A small rise in CEA is sensitive for recurrence after surgery for colorectal cancer [J]. Colorectal Dis, 2007,9 (6) : 527-531.

二级参考文献3

共引文献7

同被引文献18

  • 1程文超.囊性肾癌9例诊治体会[J].新医学,2004,35(12):738-739. 被引量:5
  • 2谢庆祥,林吓聪,张闽峰,郭以河,赵力.肾癌组织中IGF-Ⅰ和IGF-ⅠR表达及其临床意义[J].现代泌尿外科杂志,2005,10(6):317-319. 被引量:1
  • 3战扬,齐凤杰,李春宏,孔庆儒,李博.PTTG和c-Myc蛋白在直肠癌中的表达及意义[J].辽宁医学院学报,2007,28(3):56-58. 被引量:3
  • 4SCHIPS L, ZIGEUNER R, RATSCHEK M, et al. Analysis of insulin-like growth factors and insulin-like growth factor I receptor expression in renal cell carcinoma[J]. Am J Clin Pathol, 2004, 122 (6): 931- 937.
  • 5DEANGELIS T, CHEN J, WU A, et al. Transformation by the simian virus 40 T antigen is regulated by IGF-I receptor and IRS-1 signaling[ J]. Oncogene, 2006, 25 (1) : 32-42.
  • 6YUEN J S, COCKMAN M E, SULLIVAN M, et al. The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinoma[J]. Oncogene, 2007, 26 (45) : 6499-6508.
  • 7MITSIADES C S, MITSIADES N S, MCMULLAN C J, et al. Inhibition of the insulin-like growth factor receptor- 1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors [ J ]. Cancer Cell, 2004, 5 ( 3 ) : 221- 230.
  • 8Cappellani A,Zanghi A,Di Vita M,et al.Clinical and biologi-cal markers in gastric cancer:update and perspectives[J].FrontBiosci,2010,2:403-412.
  • 9Bain GH,Petty RD.Predicting response to treatment in gas-troesophageal junction adenocarcinomas:combining clinical,im-aging,and molecular biomarkers[J].Oncologist,2010,15(3):270-284.
  • 10陈月燕,席云,肖刚,魏静.荧光实时定量PCR在检测CML患者BCR-ABL融合基因中的应用[J].新医学,2007,38(9):584-586. 被引量:1

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部